The FDA has issued a warning to women using a topical estrogen hormone replacement, called Evamist, that contact with children and pets has been reported to cause adverse effects.
"Women using Evamist need to be aware of the potential risks to children who come in contact with the area of skin where this drug is applied," said Julie Beitz, M.D., director of the FDA's Office of Drug Evaluation III. "It is important that people know to keep both children and pets away from the product to minimize exposure."
FDA recommends that women using Evamist should not allow children or pets to come in contact with the area of the arm where Evamist was sprayed, not allow pets to lick or touch the arm where Evamist was sprayed. Small pets may be especially sensitive to the estrogen in Evamist. Contact a veterinarian if your pet shows signs of nipple and/or vulvar enlargement, or any other sign of illness. The FDA is recommending that if patients using Evamist know they cannot keep a child or pet from making contact with the area where the drug is sprayed, they should wear a garment that covers the area.
The FDA continues to monitor and review adverse event reports and is evaluating ways to
reduce inadvertant exposures to these products.
No comments:
Post a Comment